SCHEMBL13026533

SCHEMBL13026533

CC(C)c1cc(Oc2ccc(C(C)C)cc2Cl)cc(Oc2ccc(C(C)C)cc2Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.43
NPBWR1 P48145 1/20 0.38
MCHR1 Q99705 1/20 0.38
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PDE7A Q13946 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
PPARG P37231 2/20 0.34
PPARA Q07869 2/20 0.34
LMNA P02545 2/20 0.33
HTR2A P28223 2/20 0.33
SLC6A4 P31645 2/20 0.33
KCNH2 Q12809 2/20 0.33
CSNK2A1 P68400 1/20 0.33
NR1I2 O75469 1/20 0.33
TTR P02766 1/20 0.33
PGR P06401 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2736379 0.84 FFAR1 (0.49) FFAR1HTR2CHTR2BTTR
SCHEMBL23922346 0.84 FFAR1 (0.56) FFAR1NPBWR1MCHR1HTR2CHTR2B
SCHEMBL13026431 0.80 LMNA (0.42) FFAR1SMN1; SMN2NPSR1LMNA
SCHEMBL21620367 0.79 FFAR1 (0.65) FFAR1HTR2CHTR2BSMN1; SMN2LMNA
SCHEMBL2670001 0.77 HDAC4 (0.47) SMN1; SMN2NPSR1TAS1R3TAS1R1LMNA
SCHEMBL2736376 0.77 MPO (0.42) FFAR1NPBWR1MCHR1HTR2CHTR2B
SCHEMBL22069710 0.76 PDE7A (0.54) FFAR1NPBWR1MCHR1HTR2CHTR2B
SCHEMBL22114334 0.76 TTR (0.46) FFAR1HTR2CHTR2BLMNASLC6A4
SCHEMBL10168911 0.76 CSNK2A1 (0.56) LMNACSNK2A1
SCHEMBL2509239 0.75 PDE7A (0.56) FFAR1NPBWR1MCHR1SMN1; SMN2PDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481696-B2 Glycosylated glycopeptide antibiotic derivatives SHIONOGI & CO., LTD. (JP) 2013-07-09 US disclosed
US-20100286364-A1 GLYCOSYLATED GLYCOPEPTIDE ANTIBIOTIC DERIVATIVES SHIONOGI & CO., LTD. (JP) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286364-A1 GLYCOSYLATED GLYCOPEPTIDE ANTIBIOTIC DERIVATIVES CSGALNACT1, OGT, GALNT1 FFAR1 2228/4885NPBWR1 979/4885MCHR1 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.